Category - Developments

A patient using Titan Pharmaceuticals’ (NASDAQ:TTNP) Probuphine six-month implant containing buprenorphine as a new treatment in the battle against heroin and prescription painkiller addiction has documented his...

BioTime (NYSE MKT:BTX) has created AgeX Therapeutics, which will consolidate certain BioTime subsidiaries and programs in the field of interventional gerontology. The formation of AgeX continues the implementation of...

Jaguar Animal Health (NASDAQ:JAGX) and closely-held Napo Pharmaceuticals, which are in the process of merging, updated their commercial activities. Jaguar is launching a national TV advertising campaign this month for...

Jaguar Animal Health (NASDAQ:JAGX) and closely-held Napo Pharmaceuticals have entered into a definitive merger agreement by unanimous approval by the boards of both companies. Under the accord, Jaguar’s stockholders and...

3D Signatures (TSX-V:DXD; OTCQB:TDSGF; FSE:3D0) has successfully completed internal analytical assay validation for its Hodgkin’s lymphoma (HL) test (Telo-HL) according to FDA guidelines. Assay validation of Telo...

Jaguar Animal Health (NASDAQ:JAGX) has entered an exclusive, 60-day evaluation period, beginning April 3, with a leading multinational animal health pharmaceutical firm regarding Equilevia, Jaguar’s drug product...

Profound Medical (OTCQX:PRFMF;TSXV:PRN) announced the first TULSA-PRO patient paid procedure has been successfully conducted at the ALTA Klinik in Bielefeld, Germany under the supervision of Dr. Agron Lumiani. TULSA-PRO...

Ortho Regenerative Technologies presented results of four key scientific studies at the 2017 Orthopaedic Research Society annual meeting in San Diego, validating its product’s ability to improve the repair of...

3D Signatures (TSXV:DXD; OTCQB:TDSGF; FSE:3D0) announced that clinical study results confirm that based on a swab from the inside of a patient’s cheek, its TeloView software platform has the ability to identify patients...

Profound Medical (OTCQX:PRFMF; TSXV:PRN) has successfully completed the first sale of a TULSA-PRO system in Finland to the Turku University Hospital, in collaboration with Royal Philips, who is working in partnership...